DORCHESTER WEALTH MANAGEMENT Co boosted its position in shares of McKesson Co. (NYSE:MCK) by 6.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 21,066 shares of the company’s stock after purchasing an additional 1,211 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in McKesson were worth $3,285,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. IHT Wealth Management LLC raised its holdings in McKesson by 64.2% during the 2nd quarter. IHT Wealth Management LLC now owns 486 shares of the company’s stock worth $1,027,000 after purchasing an additional 190 shares during the last quarter. WFG Advisors LP raised its holdings in McKesson by 5.0% during the 2nd quarter. WFG Advisors LP now owns 859 shares of the company’s stock worth $141,000 after purchasing an additional 41 shares during the last quarter. CWH Capital Management Inc. bought a new stake in McKesson during the 2nd quarter worth about $165,000. Wealthcare Advisory Partners LLC bought a new stake in McKesson during the 3rd quarter worth about $155,000. Finally, BRYN MAWR TRUST Co bought a new stake in McKesson during the 2nd quarter worth about $208,000. 87.91% of the stock is owned by hedge funds and other institutional investors.
Shares of McKesson Co. (NYSE MCK) traded down $1.05 on Thursday, hitting $171.78. The company had a trading volume of 1,353,935 shares, compared to its average volume of 1,603,675. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.05 and a quick ratio of 0.61. McKesson Co. has a 1-year low of $133.82 and a 1-year high of $173.84. The firm has a market cap of $35,640.00, a price-to-earnings ratio of 8.14, a PEG ratio of 1.74 and a beta of 1.23.
McKesson (NYSE:MCK) last issued its quarterly earnings data on Thursday, October 26th. The company reported $3.28 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.78 by $0.50. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.69 billion. During the same period in the previous year, the firm earned $2.94 EPS. McKesson’s quarterly revenue was up 4.2% compared to the same quarter last year. research analysts anticipate that McKesson Co. will post 12.23 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Investors of record on Friday, December 1st were given a $0.34 dividend. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $1.36 annualized dividend and a dividend yield of 0.79%. McKesson’s dividend payout ratio is presently 6.44%.
In related news, Chairman John H. Hammergren sold 65,000 shares of the business’s stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.20% of the stock is currently owned by insiders.
A number of analysts have recently commented on MCK shares. Robert W. Baird reaffirmed a “buy” rating and issued a $200.00 price target on shares of McKesson in a research note on Wednesday. Evercore ISI started coverage on McKesson in a research note on Thursday, January 4th. They issued an “outperform” rating and a $179.00 price target for the company. Mizuho set a $168.00 price target on McKesson and gave the company a “hold” rating in a research note on Tuesday, October 24th. ValuEngine cut McKesson from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Needham & Company LLC set a $179.00 price target on McKesson and gave the company a “buy” rating in a research note on Monday, October 16th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the company. McKesson presently has an average rating of “Hold” and a consensus price target of $175.86.
WARNING: “DORCHESTER WEALTH MANAGEMENT Co Purchases 1,211 Shares of McKesson Co. (MCK)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/18/dorchester-wealth-management-co-purchases-1211-shares-of-mckesson-co-mck.html.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.